248 related articles for article (PubMed ID: 32905241)
1. Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated.
Wong MMY; Tu C; Li Y; Perlman RL; Pecoits-Filho R; Lopes AA; Narita I; Reichel H; Port FK; Sukul N; Stengel B; Robinson BM; Massy ZA; Pisoni RL;
Clin Kidney J; 2020 Aug; 13(4):613-624. PubMed ID: 32905241
[TBL] [Abstract][Full Text] [Related]
2. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.
Guedes M; Muenz D; Zee J; Lopes MB; Waechter S; Stengel B; Massy ZA; Speyer E; Ayav C; Finkelstein F; Sesso R; Pisoni RL; Robinson BM; Pecoits-Filho R
Nephrol Dial Transplant; 2021 Aug; 36(9):1694-1703. PubMed ID: 33624825
[TBL] [Abstract][Full Text] [Related]
3. Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.
Guedes M; Muenz DG; Zee J; Bieber B; Stengel B; Massy ZA; Mansencal N; Wong MMY; Charytan DM; Reichel H; Waechter S; Pisoni RL; Robinson BM; Pecoits-Filho R;
J Am Soc Nephrol; 2021 Aug; 32(8):2020-2030. PubMed ID: 34244326
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of iron status in anemic pre-dialysis chronic kidney disease patients.
Waziri B; Babawale BT; Mabayoje MO
Niger J Clin Pract; 2022 Mar; 25(3):226-230. PubMed ID: 35295041
[TBL] [Abstract][Full Text] [Related]
6. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
Stancu S; Bârsan L; Stanciu A; Mircescu G
Clin J Am Soc Nephrol; 2010 Mar; 5(3):409-16. PubMed ID: 20019121
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis.
Charytan C; Qunibi W; Bailie GR;
Nephron Clin Pract; 2005; 100(3):c55-62. PubMed ID: 15824508
[TBL] [Abstract][Full Text] [Related]
8. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
[No Abstract] [Full Text] [Related]
9. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.
Shepshelovich D; Rozen-Zvi B; Avni T; Gafter U; Gafter-Gvili A
Am J Kidney Dis; 2016 Nov; 68(5):677-690. PubMed ID: 27321965
[TBL] [Abstract][Full Text] [Related]
11. A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps.
Lopes MB; Tu C; Zee J; Guedes M; Pisoni RL; Robinson BM; Foote B; Hedman K; James G; Lopes AA; Massy Z; Reichel H; Sloand J; Waechter S; Wong MMY; Pecoits-Filho R
Sci Rep; 2021 Jan; 11(1):1784. PubMed ID: 33469061
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for anemia in the early stages of chronic kidney disease].
Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
[TBL] [Abstract][Full Text] [Related]
13. Iron Deficiency in Newly Referred Patients With Chronic Renal Failure.
Kitamura M; Yamashita H; Kuroki R; Fukuda H; Sawase A; Mukae H; Nishino T
Cureus; 2024 May; 16(5):e61076. PubMed ID: 38915962
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of iron deficiency anemia management in the general hospital of Grenoble: A 12-month follow-up of an intravenous ferric carboxymaltose treatment program in a cohort of patients with non-dialysis-dependent chronic kidney disease].
Romanet T; Bedouch P; Zaoui P
Nephrol Ther; 2019 Apr; 15(2):104-109. PubMed ID: 30803900
[TBL] [Abstract][Full Text] [Related]
16. Serum total iron-binding capacity and iron status in patients with non-dialysis-dependent chronic kidney disease: A cross-sectional study in Vietnam.
Thang LV; Kien NT; Hung NV; Kien TQ; Dung NH; Huong NTT; Toan ND; Toan PQ; Vinh HT; Nghia VX; Usui T
Asia Pac J Clin Nutr; 2020; 29(1):48-54. PubMed ID: 32229441
[TBL] [Abstract][Full Text] [Related]
17. Iron Deficiency Anemia in Chronic Kidney Disease.
Gafter-Gvili A; Schechter A; Rozen-Zvi B
Acta Haematol; 2019; 142(1):44-50. PubMed ID: 30970355
[TBL] [Abstract][Full Text] [Related]
18. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
Mariani L; Stengel B; Combe C; Massy ZA; Reichel H; Fliser D; Pecoits-Filho R; Lopes AA; Yamagata K; Wada T; Wong MM; Speyer E; Port FK; Pisoni RL; Robinson BM
Am J Kidney Dis; 2016 Sep; 68(3):402-13. PubMed ID: 27113505
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
